Status | Study |
Recruiting |
Study Name: A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804 Condition: Osteogenesis Imperfecta, Type I Osteogenesis Imperfecta Type III Date: 2017-04-03 Interventions: Drug: BPS804 Intravenous infus |
Not yet recruiting |
Study Name: Safety of Fresolimumab in the Treatment of Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 2016-10-13 Interventions: Drug: Fresolimumab The purpose of this study is to determine if fresolimumab is safe as a treatment for |
Completed |
Study Name: Repeated Infusions of Mesenchymal Stromal Cells in Children With Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Type II Osteogenesis Imperfecta Type III Date: 2010-02-01 Interventions: Biological: Mesenchymal Stromal Cells Both cohorts will receive multiple infusions of ex-vivo expanded M |
Completed |
Study Name: An Efficacy and Safety Trial of Intravenous Zoledronic Acid in Infants Less Than One Year of Age, With Severe Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 2009-09-21 Interventions: Drug: Zoledronic Acid Each patient is to receive an initial dose of zoledronic acid of 0.0125 mg per kg |
Completed |
Study Name: Treatment of Severe Osteogenesis Imperfecta by Allogeneic Bone Marrow Transplantation Condition: Osteogenesis Imperfecta Date: 2008-06-23 Interventions: Other: Bone Marrow Cell Transplantation Ra |
Completed |
Study Name: Zoledronic Acid in Children (1 -17 Years) With Severe Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 2005-08-15 Interventions: Drug: Zoledronic Acid |
Completed |
Study Name: Growth Hormone Therapy in Osteogenesis Imperfecta Condition: Osteogenesis Imperfecta Date: 1999-11-03 Interventions: Drug: Humatrope Patients recei |